DoW Melanoma Research Program Survivorship Research Award
DOD-AMRAA Posted HT942526MRPSRA
Close Date:
October 14, 2026
73 days remaining
Description
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity. Distinctive Features: · The application must include at least one melanoma consumer collaborator , defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research. · Clinical trials are allowed.
Actions
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- Not specified
- Total Estimated Funding
- $2,040,000.00
- Expected Awards
- 2
Key Dates
- Posted
- May 21, 2026
- Closes
- October 14, 2026 73d
- Archive Date
- November 13, 2026
Agency Information
- Agency Name
- Defense Health Agency Contracting Activity - DHACA
- Agency Code
- DOD-AMRAA
- Funding Instrument
- Other